HALO
Halozyme TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
HALO vs peer average
69/100
HALO vs. peer average (B vs. C)
Grade spread
A 1 · C 5 · D 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Broad large-cap biologics comp rather than a clean Halozyme analog; useful mainly as a reference for how subcutaneous biologic adoption and partner execution can affect platform royalty opportunity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
HALO
Halozyme Therapeutics
AMGN
Amgen
Grade
B
D
Momentum
50
34
Value
66
63
Sentiment
45
35
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
HALO / AMGN
Grade Position
In line
HALO vs. peer average (B vs. C)
69/100
Momentum
50
HALOValue
66
HALOSentiment
45
HALORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs HALO
AMGN is the first peer returned for this comparison set.